WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jennifer JarrettChief Operating Officer2024-03-2711,551$17.55
$202.72kSell
Jennifer JarrettChief Operating Officer2024-03-1812,153$17.84
$216.81kSell
Jennifer JarrettChief Operating Officer2024-03-181,296$18.62
$24.13kSell
Juan C. JaenPresident2024-02-2723,132$20.10
$464.95kSell
Jennifer JarrettChief Operating Officer2024-02-2734,070$20.11
$685.15kSell
Juan C. JaenPresident2024-02-263,900$20.06
$78.23kSell
Jennifer JarrettChief Operating Officer2024-02-2624,555$20.07
$492.82kSell
Gilead Sciences Inc10% Owner2024-01-2915,238,095$21.00
$320.00MBuy
Ii Robert C. GoeltzChief Financial Officer2024-01-022,004$20.00
$40.08kSell
Juan C. JaenPresident2024-01-026,975$20.09
$140.13kSell

1 of 4

RCUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc33.08%30,061,124$467.45MInsider
Terry J. Rosen17.77%16,144,460$251.05MInsider
Blackrock Inc11.04%10,035,170$156.05MInstitution
Fmr LLC5.20%4,728,782$73.53MInstitution
Vanguard Group Inc5.15%4,680,716$72.79MInstitution
State Street Corp4.67%4,239,577$65.93MInstitution
Gv 2016 GP LLC3.44%3,125,312$48.60MInsider
Gv 2017 GP LLC2.12%1,924,474$29.93MInsider
Octagon Capital Advisors LP2.06%1,868,000$29.05MInstitution
Ameriprise Financial Inc1.80%1,634,805$25.42MInstitution

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS48.32%51.68%Net BuyingNet Selling
MORF64.32%35.68%Net BuyingNet Buying
VCYT64.44%35.56%Net SellingNet Selling
NMRA21.44%78.56%Net Buying
GYRE0.37%99.63%Net BuyingNet Buying
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 58.15% institutional shareholders, 62.21% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 30.06M shares representing 33.08% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $467.45M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.